Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluocinolone Acetonide Implants for Diabetic Macular Edema
NCT00576459Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Mar 2003
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of fluocinolone acetonide in diabetic macular edema (DME), sponsored by Bausch + Lomb. Started Mar 2003; status: completed.
02
Drugs
fluocinolone acetonide
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00576459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576459.